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Abstract
INTRODUCTION Oral complications can be profound in patients undergoing cancer therapy, negatively impacting 
quality of life, and potentially postponing or disrupting treatment. While oncology team members seek to deliver op-
timal oral care, evidence-based management of oral complications and knowledge in the provision of oral care poses a 
challenge to attaining satisfactory reductions in complications such as oral mucositis, xerostomia and rampant dental 
caries.
METHODS A cross-sectional, random sample (N=2,000) of members of the Oncology Nursing Society were surveyed 
via a Web-based questionnaire to identify knowledge of oral care, oral health management practices and factors influ-
encing provision of oral care for patients being treated for cancer. Frequencies were calculated for demographic and cat-
egorical data. Education, years of experience, and comfort levels were measured and correlated to identified subscales 
of knowledge, management of oral complications, and use of evidence-based protocols for high-risk patients.
RESULTS Over 75% of respondents reported some to little oral health content in their primary education. Significant 
correlations were found between the three subscales and the variables years of experience and comfort levels (p≤0.05). 
Use of evidence-based protocols and oral management increased with levels of oral healthcare education and years of 
experience (p≤0.05).
CONCLUSION Results of this investigation suggest a need for the inclusion of more education in general nursing 
programs addressing oral healthcare of cancer patients, as well as continuing education for practicing oncology pro-
fessionals. Additionally, findings support the inclusion of dental hygienists, oral health/disease prevention experts, as 
members of interdisciplinary teams caring for cancer patients.
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© 2013 Tranmer et al. This open access article is distributed under a Creative Commons Attribution License, which allows unrestricted 
use, distribution, and reproduction in any medium, provided the original author and source are credited.
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Introduction
Assessing knowledge of oral health and practice of 
evidence-based guidelines among oncology teams 
is crucial in oral management of oncology patients 
(Barker et al., 2005; McGuire, 2003; McGuire, Johnson, 
& Migliorati, 2006; Southern, 2007; Vissink et al., 2003). 
Annually, over one million Americans are diagnosed 
with cancer and 40% of patients receiving systemic 
chemotherapy develop oral problems (American Cancer 
Society, [ACS], 2013; National Cancer Institute, [NCI], 
2013; National Institute of Dental and Craniofacial 
Research, [NIDCR], 2011). Patients undergoing cancer 
therapy are immediately at risk for short- and long-term 
oral complications when treatment begins (ACS, 2013; 
NIDCR, 2011). Oral complications can be profound, 
negatively impacting quality of life, and potentially 
postponing or disrupting cancer therapy (ACS, 2013; 
NIDCR, 2011). Short- and long-term complications 
associated with head and neck radiotherapy and/or 
systemic chemotherapies include oral mucositis, a 
painful inflammation and ulcerations in the oral tissue; 
xerostomia, severe dry mouth resulting from reduced 
or absent saliva flow; trimus, a condition limiting 
opening of jaw with painful muscle spasms; rampant 
dental caries, tooth decay that affects multiple teeth and 
progresses rapidly ; and osteoradionecrosis, a necrosis 
of the jaw bone following radiation (ACS, 2013; NCI, 
2013; NIDCR, 2011; Trotti et al., 2003). 
Oral mucositis is a common complication 
among patients with cancer undergoing systemic 
chemotherapy and/or head and neck radiotherapy 
(Arora, Keerthilatha, Maiya, Vidysagar, & Rajeev, 2008; 
Stokman et al., 2006; Trotti et al., 2003). The Mucositis 
Study Group of the Multinational Association of 
Supportive Care in Cancer (MASCC) and International 
Society for Oral Oncology (ISOO) published guidelines 
for care of mucositis based upon a systematic review of 
the literature (Keefe et al., 2007). These guidelines are 
similar to those found in other cancer resources, such 
as those published by NCI and NIDCR. A systematic 
review by Keefe et al. (2007) concluded, depending on 
severity, mucositis can cause serious complications to 
a patient’s ability to eat and maintain a healthy weight. 
The author also reported cancer treatment may be 
suspended or discontinued due to severity of mucositis 
(Keefe et al., 2007).
Xerostomia is another common short-term 
complication resulting from systemic chemotherapy, 
head and neck radiation, medication, and/or illness. 
It results from reduction of salivary output (chemical 
composition) and flow from salivary glands (Al 
Nawas & Grötz, 2006). In a clinical trial by Papas, 
Russell, Singh, Kent, Triol & Winston  (2007) dramatic 
reduction of saliva was noted within the first weeks of 
high-dose systemic cytotoxic agents or head and neck 
radiotherapy (Papas et al., 2007). Without regular oral 
             Implications for Interprofessional Practice
•	 Emphasizes the presence of specialized oncology members with knowledge and training in oral 
health, or utilizing an oral health liaison, as being crucial for the implementation of evidence-based 
oral management of oncology patients.
•	 Describes a need to increase access to and use of current evidence-based guidelines and validated 
assessment tools for oral complications, as well as modalities for management of oral complications.
•	 Provides published oral management guidelines to assist oncology professionals in the provision of 
standardized care for patients.
•	 Stresses importance of knowledge of oral health throughout all phases of cancer therapy and the 
use of guidelines for oral care among oncology teams as critical to the overall management of these 
patients. 
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assessment and preventive measures, xerostomia can be 
directly related to rampant dental caries. If xerostomia 
is not managed eff ectively, teeth can be destroyed in a 
matter of months and can lead to osteoradionecrosis if 
not addressed properly. (ACS, 2013; NCI, 2013; NIDCR, 
2011; Shiboski, Hodgson, Ship, & Schiødt, 2007).
Literature Review
Oral health professionals have been identifi ed in the 
literature as a valuable component to the oncology team 
(ACS, 2013; NCI, 2013; NIDCR, 2011). Th eir expertise 
in oral disease and health promotion can provide 
needed oral health evaluation prior to cancer therapy 
by addressing existing oral health issues which could 
impact cancer therapy, as well as  through assessment/
treatment of oral complications (for example, see Figure 
1) associated during and aft er completion of cancer 
therapy (ACS, 2013; Barker et al., 2005; Keefe et al., 
2007; McGuire, 2003; McGuire, Johnson, & Migliorati 
2006; NCI, 2013; NIDCR, 2011; Öhrn & Sjödėn, 2003; 
Southern, 2007; Vissink et al., 2003). Th e role of the 
oral health professional may positively aff ect treatment 
outcomes for patients with various cancers, whether 
through direct patient care or educating oncology 
teams on evidence-based practices. Multidisciplinary 
approaches that include dental professionals have not 
been integrated into this population’s total care (ACS, 
2013; Barker et al., 2005; Keefe et al., 2007; McGuire, 
2003; McGuire, Johnson, & Migliorati 2006; NCI, 2013; 
NIDCR, 2011; Öhrn & Sjödėn, 2003; Southern, 2007; 
Vissink et al., 2003).
In each phase of cancer therapy, patients need oral 
assessment, oral self-care education, and preventive 
therapy measures. Frequent oral assessments using 
evidence-based indices are recommended throughout 
cancer therapy (Keefe et al., 2007; NCI, 2013; NIDCR, 
Figure 1
Ulceration and Pseudomembranous Mucosa
Public domain image from Hsiao, G., & Sonis, S. (2003). Oral mucositis. In M. B. Max & J. Lynne 
(Eds.), Interactive Textbook on Clinical Symptom Research. Bethesda, MD: National Institute of 
Dental and Craniofacial Research. http://painconsortium.nih.gov/symptomresearch/index.htm
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2011; Trotti et al., 2003). Several oral indices have been 
included in published guidelines; however, all indices 
should document occurrence of oral complications 
and employ a scale to rate severity. A systematic review 
of interventions for the management of mucositis 
conducted by the Oncology Nursing Society (ONS) 
Putting Evidence Into Practice® (PEP) Group concurred 
with the need for use of valid and reliable assessment 
tools to improve comparison of interventions. This 
group also found evidence supporting oral mucositis 
management strategies and identified these techniques 
as promising approaches for future interventions 
(Harris, Eilers, Harriman, Cashavelly & Maxwell, 
2008). Despite the availability of assessment tools and 
universal protocols, research has suggested oncology 
health care providers do not fully utilize these tools 
in oral management of oncology patients (McGuire, 
2003).
Investigators in Sweden, The Netherlands, and the 
United States have conducted surveys among oncology 
staff to evaluate oral health knowledge level and patient 
management protocols related to oral complications of 
patients undergoing cancer therapy (Barker et al., 2005; 
McGuire, 2003; McGuire et al., 2006; Öhrn, Wahlin, & 
Sjödén, 2001; Öhrn, & Sjödén, 2003; Southern, 2007). 
Findings of research evaluating oncology nurses’ 
knowledge of oral health indicated both professional 
nursing programs and continuing education (CE) 
courses needed to either add or extend their didactic/
clinical content regarding oral health assessment and 
therapeutic strategies associated with cancer care 
(Öhrn, Wahlin, & Sjödén, 2001; Öhrn, & Sjödén, 2003; 
Southern, 2007). These educational experiences and 
introduction of evidence-based protocols are needed 
to keep professionals informed of current information 
and effective interventions to manage common oral 
complications (Barker et al., 2005; McGuire, 2003; 
McGuire et al., 2006; Öhrn, Wahlin, & Sjödén, 2001; 
Öhrn, & Sjödén, 2003; Southern, 2007).
A survey of nurses involved with cancer care in Ireland 
showed nearly half of respondents had received 
some educational content on oral healthcare/patient 
management during their primary nursing education. A 
large portion of respondents (43%), however, reported 
no education during their primary training regarding 
oral care related to cytotoxic agents or radiation 
therapy (Southern, 2007). In addition, Southern (2007) 
found nurses self-rated their knowledge about saliva 
substitutes, oral health status, and signs and symptoms 
of oral complications as poorest (no knowledge) on a 
5-point Likert scale. 
Three key principles regarding provision of oral 
care during cancer therapy have been identified for 
oncology teams: “1) recognizing oral care is medically 
necessary in patients with cancer; 2) collaborating 
with members of other healthcare disciplines; and 
3) engaging in evidence-based practice to the fullest 
extent possible” (McGuire 2003,  p.438).  Moreover, 
McQuire (2003) found nurses’ recommendations for 
high-risk management of oral complications were 
sometimes based on subjective evaluation and anecdotal 
knowledge; evidence-based modalities were not 
standard protocols in treatment of oral complications 
associated with cancer therapy. 
The present study was designed to evaluate oncology 
team members’: (a) education in and knowledge of oral 
disease/oral complications associated with cancer care 
based on didactic study within their professional or 
continued education; (b) patient management practices 
of oral complications during cancer care; (c) comfort 
level performing oral care for patients with cancer; 
and (d) knowledge/education, comfort levels, and oral 
management of complications based on demographic 
characteristics.  
Methods
A Web-based survey was used to assess knowledge 
and educational levels regarding oral care, 
management practices related to oncology care for 
oral complications, and other influences affecting oral 
care of cancer patients by oncology nurses. The survey 
instrument used, National Survey of Oncology Teams’ 
Knowledge and Education about Oral Care in Cancer, 
was developed and validated in Ireland by Southern 
(2007). The instrument was reviewed for this study 
by an oncology nurse in the U.S.A. for applicability 
of responses, and minor modifications were made in 
verbiage for American English and regional professional 
terminology. The revised questionnaire was pilot tested 
by a small convenience sample (N=8) of two oncology 
nurses and six registered dental hygienists (RDH).
The coded questionnaire contained 44 items related 
to oral health knowledge and education, evidence-
based management of oral complications, evidence-
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based management of patients at high risk of oral 
complications, comfort-level in examining and assessing 
oral conditions, and demographic characteristics of the 
respondents. Types of questions in the survey included 
5-point Likert-type and closed-response multiple-
choice items. 
A cross-sectional, random sample of active members 
within the Oncology Nursing Society (N=2,000) was 
invited to participate. Inclusion criteria specified all 
participants be: a) a registered nurse (RN), RN with 
specialized oncology training, licensed independent 
practitioner (LIP), dietician, or oral health professional; 
b) directly involved with oral care of oncology patients; 
c) employed a minimum of 20 hours per month; and d) 
working for a minimum of one year. 
Following approval by the University’s Institutional 
Review Board (IRB), an invitation link to the survey was 
sent via e-mail directly from the ONS online database. 
The link directed respondents to a Web-based survey 
site where informed consent and the survey instrument 
(questionnaire) were available. Two follow-up emails 
were sent to non-respondents.
Data analyses 
Statistical analyses included generating descriptive 
statistics (frequencies and percentages) for all items, 
and data were subsequently analyzed using factor 
analysis to guide the formation of subscales. Bivariate 
analyses (Pearson’s Correlation Coefficient [2-tailed], 
Spearman’s Rank Correlation Coefficient [2-tailed], and 
independent samples t-tests [2-tailed]) were conducted. 
These tests were used to assess strength and direction 
of relationships among the subscales, and between 
the subscales and the comfort level and demographic 
variables.  Pearson’s Correlation Coefficient explored 
correlations between the identified subscales and years 
of experience. Spearman’s Rank Correlation Coefficient 
evaluated correlation of subscales and comfort levels 
in performing and educating oral complications and 
high-risk patient management associated with cancer 
therapy. The independent samples t-test was used to 
compare the subscale scores between those with and 
without oncology training. Exploratory factor analysis 
was performed to identify underlying subscales (such 
as knowledge of oral care) within the instrument. 
In addition to factor analysis, Cronbach’s alpha was 
calculated to determine internal reliability of items 
within the three subscales: oral health knowledge, 
evidence-based management of oral complications, 
and evidence-based management of high-risk patients 
by professionals; p ≤ 0.05 was considered significant. 
Results
A total of 113 surveys were completed and returned 
for a response rate of 6%. All of the 113 respondents 
were females. Of the 102 respondents who specified 
a profession, the sample included RNs, RNs with 
specialized oncology training, LIPs, and one RDH. 
Experience ranged from 1 to over 30 years, and 
respondents were drawn from all regions of the U.S. 
Demographic characteristics of participants are 
summarized in Table 1 (following page). Twenty-four 
ordinal scale items were analyzed for identification 
of constructs. Table 2 (page 7) shows the three 
constructs that were identified and questionnaire 
items associated with each construct. Cronbach’s alpha 
analysis confirmed internal consistency reliability 
within the instrument (knowledge of oral care: 0.871; 
evidence-based management of oral complications: 
0.870; evidence-based practice with high-risk patients: 
0.820). Frequencies and percentages of responses 
from specific survey items within the three identified 
constructs are given in Table 3 (page 8). Pearson’s 
correlation coefficient, as shown in Table 4 (page 9), 
identified significant linear correlations between the 
three constructs and years of experience in oncology. 
There were no significant differences in the mean 
subscale scores between those who did and did not 
have oncology training.
Statistically significant correlations were found between 
the constructs of knowledge of oral care and evidence-
based management of oral complications (r=0.494; 
n=104; p<0.001) and knowledge and evidence-based 
management of high-risk patients (r=0.531; n=104; 
p<0.001). Significant correlations among constructs 
were also found between evidence-based management 
of oral complications and evidence-based practice 
with high-risk patients (r=0.606; n=111; p<0.001). 
Spearman’s Rank Correlation showed no significant 
association between knowledge of oral health and 
education specific to cytotoxic agents and radiation. 
The second construct, evidence-based management 
of oral complications, was significantly associated 
with education regarding cytotoxic agents and 
radiation (r=0.286; n=104; p=0.003); however, no 
H IP& Oral Care in Cancer Therapy
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Demographic Characteristics Respondents (n=) Percent (%)*
Employment Setting (n=102)
• Both inpatient and outpatient
• Inpatient ward/settings 
• Outpatient clinics 
• Other
18
33
43
8
11
32
42
8
Age (n=103)
• 20-39
• 40-59
• 60+
26
67
10
25
65
10
Years of Experience (n=103)
• 1-4 yrs
• 5-9 yrs
• 10-15 yrs
• 16-20 yrs
• 21-24 yrs
• 25-29 yrs
• 30+ yrs
14
22
20
9
12
15
11
14
21
19
9
12
15
10
Employment Status (n=102)
• Full time
• Part time
97
5
95
5
Continuing Education on Oral Health within last year (n=102)
• < 1 hr
• 1-2 hrs
• 2-4 hrs
• 5-8 hrs
• > 8 hrs
61
22
10
5
4
60
22
10
5
4
Profession (n=102)
• Licensed Independent Practitioner
• Oncology Nurse
• Registered Nurse
• Dental Hygienist
11
76
14
1
11
74
14
1
Region of the Country  (n=103)
• Midwest
• Northeast
• South
• West
32
25
25
21
31
24
24
20
*Not all percentages total 100% due to participants’ lack of response to some items
Table 1
Numeric variables collected
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Identified Constructs  Scale Items 
(Factor Loading >.3)
Mean Rating
Score
Knowledge of Oral Care
(n=104)
*
1. toothbrushing
2. oral rinsing
3. saliva substitutes
4. examination of oral cavity
5. cleaning dentures/partials
6. pain relief of the oral cavity
7. cleaning the oral mucosa
3.8
Evidence-based Management of 
Oral Complications
(n=111)
            
**
1. How often are patients informed of oral complications associated 
with cancer treatment?
2. How often are patients informed of the complication - 
candidiasis?
3. How often are patients informed of the complication - mucositis?
4. How often are patients informed of the complication - infection?
5. How often are patients informed of the complication - pain?
4.3
Evidence-based Management of 
High Risk Patients
(n=111)
**
1. To what extent are high-risk patients provided oral self care 
information?
2. To what extent are preventive recommendations performed with   
high-risk patients?
3. To what extent do you provide oral care recommendations to 
oncology patients with oral complications?
4.3
*Likert Scale: 1=None; 2=Marginal; 3=Fair; 4=Good; 5=Excellent
**Likert Scale: 1=Never; 2=Seldom; 3=Some of the time; 4=Most of the time; 5=All of the time
Table 2
Factor Analysis Identifying Constructs
H IP& Oral Care in Cancer Therapy
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Table 3
Frequencies and Percentages of Responses within 3 Identified Constructs
Participants’ Self-Rating of Knowledge Levels Regarding Oral 
Health
A Lot Some A
Little
None Don’t
Remember
Oral health education in professional training 
(n=106)                                  
n=3
 3%
n=38
36%
n=45
42%
n=3
 3%
n=17
16%
Content on cytotoxic drugs and radiation therapy side effects in 
professional training 
(n=106)
n=4
 4%
n=28
26%
n=41
39%
n=23
22%
n=10
 9%
Oral health education in specialized oncology training program 
(n=100)
n=47
47%
n=42
42%
n=9
 9%
n=1
 1%
n=1
 1%
Oral assessment indices used 
(n=94)
OHRQoL
n=3
 3%
OHI
n=2
 2%
WHO 
(OMI)
n=66
70%
None
n=19
20%
Other
n=4
 4%
Evidence-based Management of Oral Complications Always Most Some Seldom Never
How often patient is informed about candidiasis 
(n=102)
n=33
32%
n=31
30%
n=27
26%
n=10
10%
n=1
 1%
How often patient is informed about mucositis 
(n=101)
 n=53
52%
n=40
40%
n=7
 7%
n=1
 1%
n=0
How often patient is informed about oral infection 
(n=103)
n=43
42%
n=43
42%
n=13
13%
n=4
 4%
n=0
How often patient is informed about oral pain 
(n=101)
n=42
42%
n=46
46%
n=12
12%
n=1
 1%
n=0
Oral Health Management Practices with High-Risk Patients Always Most Some Seldom Never
Examination of oral cavity 
(n=101)
n=13
13%
n=37
37%
n=20
20%
n=30
30%*
n=1
 1%
Provision of oral self-care instructions 
(n=103)
n=52
50%
n=29
28%
n=17
17%
n=5
5%
n=0
Assistance with oral self-care 
(n=103)
n=19
18%
n=2
 2%
n=17
17%
n=35
34%
n=19
18%
Provision of preventive protocols 
(n=103)
n=42
41%
n=38
37%
n=16
16%
n=5
 5%
n=2
 2%
Satisfaction with Time Allowed for Oral Care 
(n=100)
n=7
 7%
n=48
48%
n=32
32%
n=11
11%
n=2
 2%
OHR Qol: Oral Health-Related Quality of Life; OHI: Oral Health Index; 
WHO (OMI): World Health Organization (Oral Mucositis Index)
H IP&ISSN 2159-1253
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Table 4
Years in Oncology in Oral Care of Cancer Patients Correlated to Knowledge of Oral Care, 
Management of Oral Complications and High-risk Patients
Subscale Correlation to Extent of Training  
Knowledge of Oral Care
(n=104)
r=0.209*
p=0.033**
Evidence-based Management of Oral Complications
(n=111)
r=0.215*
p=0.023**
Evidence-based Management of High-risk Patients
(n=111)
r=0.275*
p=0.004**
*Pearson’s Correlation Coefficient
**p≤0.05
significant correlation was found between the third 
construct of evidence-based practice with high-risk 
patients and education regarding cytotoxic agents and 
radiation. All three constructs: 1) knowledge of oral 
care (r=0.312; n=104; p=0.001), 2) evidence-based 
management of oral complications (r= 0.247; n=111; 
p=0.009), and 3) evidence-based practice with high-
risk patients(r=0.342; n=111; p=<0.001) were found to 
be significantly correlated with comfort in discussing 
oral care and comfort in examining the oral cavity. 
Findings indicate as comfort levels of practitioners 
increased, both knowledge of oral care and evidence-
based management of oral complications increased. 
Discussion
Oral health professionals are not standard members of 
oncology teams, although their expertise in oral disease 
and health promotion could positively affect oral health 
of patients prior to cancer therapy, standardization of 
oral assessment tools, and evidence-based oral health 
management (Barker et al., 2005; McGuire, 2003; 
McGuire, Johnson, & Migliorati, 2006)  Studies have 
indicated the importance of knowledge of oral health 
in all phases of cancer therapy and use of guidelines 
for oral care among oncology teams as being critical to 
the overall management of these patients (Keefe et al., 
2007; NCI, 2013; NIDCR, 2011). Sound educational 
training in oral care protocols can provide an important 
foundation for total care (Barker et al., 2005; McGuire, 
2003; McGuire, Johnson, & Migliorati, 2006; Southern, 
2007; Vissink et al., 2003). Respondents reported their 
primary professional education provided minimal 
content regarding oral health. Furthermore, our 
findings indicate oral complications, specifically with 
cytotoxic drugs and radiation therapy, were minimally 
addressed in general professional programs; however, 
extensive content regarding oral health within 
specialized oncology education was reported by nearly 
half of responding oncology professionals, and an 
additional forty percent reported some content. 
Published oral management guidelines, knowledge of 
oral care, and use of validated assessment tools can 
assist in the provision of standardized care for oncology 
patients (McGuire, 2003; NCI, 2013; NIDCR, 2011). 
The majority of respondents in this study reported oral 
assessment indices were useful, and most were using 
the World Health Organization Oral Mucositis Index 
(WHO OMI) for assessment of mucositis. Although 
not specifically addressed in this study, Southern 
(2007) reported a lack of training on how to use oral 
assessment tools in primary professional education. 
Twenty percent of respondents in this study were not 
using any form of oral assessment index to aid in the 
identification and management of oral complications. 
H IP& Oral Care in Cancer Therapy
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Table 5
Validated Oral Assessment Tools
World Health Organization (WHO)
•	 Oral Mucositis Assessment Scale (OMAS)
Primary indicators of mucositis were the degrees of ulceration and redness measured in specific sites in the mouth. 
Secondary indicators included oral pain, difficulty swallowing, and the ability to eat as assessed by the patient.
Source: http://painconsortium.nih.gov/symptomresearch/chapter_17/sec7/cghs7pg1.htm
•	 Oral Mucositis Index (OMI)
The OMI-20 consists of nine items measuring erythema, nine measuring ulceration, one measuring atrophy, and one 
measuring edema.
Source: http://www.ncbi.nlm.nih.gov/pubmed/12449720
National Cancer Institute (NCI)
•	 National Cancer Institute Common Toxicity Criteria (NCI-CTC)
Scoring Criteria includes more than 260 individual adverse events with more than 100 of these applicable to acute radiation 
effects.
Source: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcmanual_v4_10-4-99.pdf
Table 5 (below) presents an overview of validated oral 
assessment tools. These findings emphasize, while 
oncology team members are aware of assessment 
protocol recommendations, there may be a need for 
standardized courses or specialized training on how 
to implement evidence-based oral care practices into 
oncology settings. According to the ONS mucositis PEP 
group (Harris, 2008), CE for oncology nurses should 
include evidence-based oral assessment guides to help 
prevent, document, and/or manage oral complications 
from cancer treatment. See Table 6 (following page) 
for evidence-based recommendations for referral and 
oral management in cancer therapy. The inclusion of 
an oral health professional in an oncology team could 
provide direct patient care and educate other oncology 
team members on evidence-based guidelines and 
management of oral complications (Barker et al., 2005; 
McGuire, 2003; McGuire, Johnson, & Migliorati, 2006; 
Southern, 2007; Vissink et al., 2003).
Significant, direct associations were identified 
between management of oral complications and 
years of experience in oncology.  This study’s results 
show a direct association between respondents’ self-
reported knowledge of oral care recommendations/
management and years of practice in an oncology 
setting.  Although updates of oral care protocols 
through CE may be valuable for educating oncology 
healthcare professionals who have minimal specialized 
oncology training, research has shown it has not 
necessarily changed implementation of those protocols 
into practice (Bloom, 2005; Robertson & Jochelson, 
2006). It is not surprising to see significant correlations 
between increased experience and incorporation of 
management protocols for oral complications; still 
over half of respondents were seldom to never assisting 
patients with their oral care.
This survey had a low response rate, as anticipated, in 
proportion to the total emails sent by the ONS despite 
repeated attempts made to increase response rate. 
Based on the organization’s documented response rate 
history for surveys within their member database, 
the Director of Communications for the Association 
indicated low response was common with this 
professional population.  According to Colbert, Diaz-
Guzman, Myers, & Arroliga (2013) while popularity 
of online surveys has increased, overall response rates 
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Table 6
Evidence-based Recommendations for Referral and Oral Management in Cancer Therapy
National Institute of Dental Craniofacial Research (NIDCR)
http://www.nidcr.nih.gov/OralHealth/Topics/CancerTreatment/
Referral To Oral Health Professionals Oral Management in Cancer Therapy
Before Cancer Treatment
To treat existing oral disease prior to initiation of cancer 
therapy.
During Cancer Treatment 
Planning and communication is important with oral health 
professionals. If dental work is needed,  blood work is needed 
to evaluate:
•	 platelet count
•	 clotting factor
•	 absolute neutrophil count
After Cancer Treatment
Every 4 to 6 weeks for 6 months following cancer treatment.
Frequent intake of water
Thorough oral hygiene 
•	 Use extra-soft manual toothbrush
Quality Nutrition
•	 Avoid sugar candies & spicy/acidic foods
Mouth rinses
•	 Topical analgesics and anesthetics  suspensions
•	 ¼ tsp salt & baking soda in 1 qt.
(omit salt with mucositis)
Fluoride application
•	 1.1% Neutral pH sodium, unflavored
•	 0.4% Stannous 
(Daily:10 minute of fluoride in mouth trays or brush-on)
High-risk inpatient and outpatient oral assessment is needed.
National Cancer Institute (NCI)
http://www.cancer.gov/cancertopics/types/oral
Referral to Oral Health Professionals Oral Management in Cancer Therapy
Before Cancer Treatment
To treat existing oral disease.
During Cancer Treatment
For treatment of pain or tooth infection (high-risk for oral 
complications).
After Cancer Treatment
To educate and manage long-term complications:
•	 Xerostomia
•	 Dental caries
•	 Osteoradionecrosis
Mucositis: Sodium bicarbonate rinses, analgesics.
Infections: Referral.
Salivary dysfunction- Frequent water intake, salivary substitutes.
High-risk inpatient and outpatient oral assessment is needed.
Clinical Guidelines by Multi-National Association of Supportive Care in Cancer (MASCC/ISOO)
Referral to Oral Health Professionals Oral Management in Cancer Therapy
Develop multidisciplinary protocols.
Frequent communication and referral to oral professional.
•	 Soft toothbrush
•	 Morphine for mucositis pain
•	 DO NOT use 0.12% chlorhexidine rinses or lozenges
•	 Use radio protective agents, or salivary sparing 
techniques
Both high-risk and outpatient oral assessment is needed:
•	 To evaluate mucositis for severity & pain level.
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have decreased significantly over the past few decades. 
These authors also assert that the representativeness of 
the sample is much more critical than the low response 
rate (Colbert, Diaz-Guzman, Myers, & Arroliga, 2013) 
The response rate found in this study, though far from 
ideal, may reflect this trend or may reflect a lower 
response rate sometimes found with online surveys of 
medical professionals (8.7%; Aitken, Power, & Dwyer, 
2008) and surveys seeking information about an 
organization/team (18.8%; Baruch & Holtom, 2008). 
While results of this study are not generalizable to the 
population of oncology nursing professionals, they do 
support results from earlier research studies related to 
nurses’ knowledge, education, and practices regarding 
oral care management of oncology patients. Despite 
previously established internal reliability and content 
validity of the survey constructed by Southern (2007), 
analyses of responses from this study using the original 
instrument showed nine items that were either unclear 
or had no theoretically correct response. Should the 
original instrument be used in future studies, these 
items would need revision. 
Conclusions 
This investigation recognizes and supports the existing 
literature which describes a need to increase access 
to and use of current evidence-based guidelines and 
validated assessment tools for oral complications, as well 
as modalities for management of oral complications. 
This study also emphasizes the presence of specialized 
oncology members with knowledge and training in oral 
health or an oral health liaison as being crucial for the 
implementation of evidence-based oral management 
of oncology patients. It also sets the groundwork for 
the inclusion of licensed dental hygienists as members 
of oncology care teams. By the nature and content of 
dental hygiene education, licensed dental hygienists 
are already trained to assist, collaborate, and provide 
education in oral care for patients undergoing cancer 
therapy. Additional research is needed to examine 
whether increased knowledge and education of oral 
health among oncology teams positively impacts 
oncology patient outcomes.  Furthermore, future 
studies could examine how technology or interactive 
CE courses might positively impact standardization of 
protocols among oral management of cancer therapy. 
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